Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Diabetic dyslipidaemia.

Martin Adiels¹, Sven-Olof Olofsson, Marja-Riitta Taskinen

¹Sahlgrenska Center for Metabolism and Cardiovascular Research, Wallenberg Laboratory for Cardiovascular Research and the Department of Metabolism and Cardiovascular Research, The Sahlgrenska Academy at Göteborg University, Göteborg, Sweden.

Current Opinion in Lipidology

|May 9, 2006

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A pcyt-1 Allelic Series Reveals In Vivo Consequences of Reduced Phosphatidylcholine Synthesis in C. elegans.

G3 (Bethesda, Md.)·2026

Same author

Linking Lipidomics to Vulnerable Coronary Plaques: A PROSPECT II Substudy.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Integrative analysis of left ventricle and epicardial adipose tissue identifies SDHA and OGDH as candidate targets for ischemic heart disease.

iScience·2026

Same author

Angiopoietin-like protein 3 complete and partial deficiency markedly accelerates apolipoprotein B48 and B100 metabolism in triglyceride-rich lipoproteins in humans.

Journal of internal medicine·2026

Same author

Phospho-JNK agonists show promising effects for the treatment of hepatocellular carcinoma.

iScience·2026

Same author

A <i>pcyt-1</i> Allelic Series Reveals In Vivo Consequences of Reduced Phosphatidylcholine Synthesis in <i>C. elegans</i>.

bioRxiv : the preprint server for biology·2026

Same journal

Editorial introduction.

Current opinion in lipidology·2026

Same journal

Heterozygosity for pathogenic variants in familial chylomicronemia syndrome genes: from carrier state to complex trait.

Current opinion in lipidology·2026

Same journal

Premature atherosclerotic cardiovascular disease in the MENA region: economic impact, barriers to care, and policy recommendations for an escalating crisis.

Current opinion in lipidology·2026

Same journal

The role of metabolic profiling and dietary intervention in the early diagnosis and prevention of atherosclerosis.

Current opinion in lipidology·2026

Same journal

A JAK of two trades: beneficial or adverse effects of Janus kinase inhibition for plasma LDL-cholesterol and major adverse cardiovascular events in inflammatory bowel disease patients?

Current opinion in lipidology·2026

Same journal

Inflammation and atherosclerotic cardiovascular disease: where do we go from here?

Current opinion in lipidology·2026

See all related articles

Diabetic dyslipidaemia involves altered very low-density lipoprotein (VLDL) assembly in type 2 diabetes, leading to overproduction of large type 1 VLDL particles. Understanding these mechanisms is key for targeted lipid management in diabetic patients.

Area of Science:

Endocrinology
Metabolic Syndrome
Lipid Metabolism

Background:

Diabetic dyslipidaemia is characterized by lipid and lipoprotein abnormalities.
Type 2 diabetes is associated with increased large type 1 very low-density lipoprotein (VLDL) particles, contributing to atherogenic remnants.

Purpose of the Study:

To elucidate the mechanisms behind the overproduction of large VLDL particles in diabetic dyslipidaemia.
To review the pathophysiology of VLDL metabolism and lipid management strategies in type 2 diabetes.

Main Methods:

Review of current literature on VLDL metabolism in type 2 diabetes.
Analysis of data correlating triglyceride and apolipoprotein B production in VLDL subpopulations.

Main Results:

Related Experiment Videos

Triglyceride and apolipoprotein B production in types 1 and 2 VLDL are correlated, indicating coupled metabolism.
Insulin resistance, hyperglycemia, and liver fat are linked to excess hepatic production of type 1 VLDL.
Data support independent regulation of type 1 and type 2 VLDL apolipoprotein B production.

Conclusions:

VLDL assembly is fundamentally altered in type 2 diabetes, causing overproduction of large type 1 VLDL.
Insulin's inability to suppress type 1 VLDL production contributes to dyslipidaemia in type 2 diabetes.
Further research into regulatory steps may enable more targeted treatments for diabetic dyslipidaemia.